7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 
      
    		                                   
      cash flows from operating activities:
    		                                   
      net income
    		-2,365,000 -7,155,000 9,602,000 -17,062,000 -137,067,000 -3,660,000 19,930,000 -17,109,000 34,753,000 39,257,000 28,733,000 13,042,000 10,031,000 -32,860,000 11,817,000 -20,232,000 -5,067,000 -8,511,000 -20,375,000 -44,112,000 -29,184,000 -25,920,000 -7,804,000 22,675,000 34,397,000 36,133,000 69,805,000 51,778,000 46,285,000 39,091,000 36,708,000 10,078,000 21,966,000 4,920,000 -24,351,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                   
      depreciation and amortization
    		41,660,000 43,309,000 48,681,000 47,706,000 54,299,000 57,522,000 52,206,000 23,430,000 53,769,000 52,889,000 50,798,000 34,374,000 30,417,000 31,463,000 31,854,000 33,124,000 33,532,000 33,243,000 33,478,000 35,446,000 37,467,000 40,172,000 40,205,000 39,052,000 37,653,000 35,482,000 33,117,000 24,710,000 23,217,000 21,275,000 18,936,000 17,026,000 14,745,000 12,706,000 11,151,000 
      property and equipment impairment expense
    		                                   
      deferred income tax expense
    		-701,000 687,000 2,844,000   2,417,000 7,940,000 -913,000 9,856,000 11,090,000 7,807,000 6,139,000 2,395,000 -8,147,000 3,826,000      -7,717,000 -6,461,000 -1,312,000 6,135,000 11,686,000 9,854,000 21,083,000 15,158,000 12,954,000 11,538,000 10,054,000 3,264,000 55,000 56,000 55,000 
      amortization of deferred debt issuance costs
    		134,000 105,000 111,000 111,000 110,000 109,000 108,000 109,000 110,000 76,000 64,000 65,000 65,000 521,000 134,000 137,000 136,000 135,000 134,000 136,000 137,000 135,000 135,000 137,000 136,000 135,000 134,000 108,000 104,000 102,000 89,000 81,000 82,000 82,000 3,158,000 
      stock-based compensation
    		4,625,000 4,733,000 3,337,000  4,615,000 4,618,000 3,742,000  3,310,000 3,758,000 3,536,000  3,306,000 3,458,000 11,364,000  3,009,000 2,909,000 2,487,000  2,535,000 2,962,000 471,000  577,000 2,840,000 1,829,000  1,631,000 1,443,000 758,000  752,000 609,000 7,369,000 
      loss on disposal of assets
    		-674,000 4,346,000 9,746,000  2,149,000 3,277,000 6,458,000 43,605,000 4,265,000 3,065,000 22,080,000 26,910,000 36,637,000 22,486,000 16,117,000 24,146,000 12,424,000 15,024,000 13,052,000 18,261,000 11,287,000 8,734,000 19,854,000 25,234,000 31,153,000       10,115,000 8,742,000 9,787,000 10,442,000 
      unrealized (gain) loss on short-term investment
    		  -183,000                                 
      business acquisition contingent consideration adjustments
    		-4,600,000 -100,000 -300,000                                 
      changes in operating assets and liabilities:
    		                                   
      accounts receivable
    		1,500,000 29,985,000 -44,716,000 29,622,000 -4,765,000 63,338,000 -36,697,000 32,424,000 -9,654,000 39,021,000 -74,199,000 15,474,000 -28,496,000 -9,846,000 -44,032,000 21,502,000 -11,482,000 -28,064,000 -25,698,000 10,419,000 -29,109,000 160,667,000 -14,486,000 63,091,000 95,731,000 -14,483,000 -154,516,000 49,434,000 64,109,000 -63,382,000 -53,461,000 -39,609,000 -12,227,000 -37,954,000 5,313,000 
      other current assets
    		-412,000 -2,314,000 411,000 -1,821,000 88,000 -998,000 430,000 1,753,000 -1,601,000 -515,000 -468,000 30,001,000 -30,208,000 405,000 156,000 -15,000 0 0 325,000 -620,000 985,000 475,000 1,138,000 748,000 7,000 870,000 -274,000 638,000 -48,000 -45,000 -338,000 33,000 -152,000 2,955,000 468,000 
      inventories
    		466,000 -3,044,000 2,824,000 581,000 1,998,000 706,000 -1,742,000 -1,497,000 2,272,000 -426,000 -6,366,000 118,000 -451,000 -1,196,000 1,653,000 -473,000 -836,000 -312,000 401,000 -880,000 956,000 491,000 -860,000 -586,000 3,229,000 792,000 482,000 328,000 1,063,000 -232,000 -1,327,000 2,963,000 -4,328,000 334,000 -441,000 
      prepaid expenses
    		684,000 4,801,000 1,390,000 -3,639,000 2,169,000 1,267,000 1,530,000 -5,868,000 -131,000 404,000 -548,000 -2,104,000 -496,000 1,636,000 1,707,000 -1,564,000 -1,684,000 4,328,000 3,383,000 -4,973,000 -1,092,000 2,913,000 2,920,000 -6,359,000 556,000 658,000 759,000 -3,683,000 557,000 2,450,000 -742,000 442,000 1,411,000 -2,991,000 670,000 
      accounts payable
    		8,480,000 -20,995,000 23,456,000 -32,568,000 -26,679,000 -26,445,000 21,191,000 -21,013,000 12,744,000 -32,983,000 29,823,000 20,311,000 7,543,000 9,609,000 -10,035,000 -12,473,000 19,304,000 26,354,000 18,579,000 1,683,000 38,212,000 -145,672,000 10,080,000 -13,746,000 -54,029,000 -2,791,000 45,324,000 -16,658,000 -32,731,000 20,359,000 38,750,000 22,664,000 44,376,000 12,072,000 -14,884,000 
      accrued and other current liabilities
    		-5,174,000 -13,000 -2,514,000 -3,214,000 -9,860,000 3,444,000 -876,000 10,427,000 10,235,000 -2,209,000 7,978,000 -21,381,000 40,219,000 3,155,000 609,000  -420,000 2,923,000 -2,095,000  -3,361,000 796,000 -9,431,000  -4,257,000 13,665,000 -1,366,000  -5,557,000       
      net cash from operating activities
    		41,660,000 54,214,000 54,689,000 37,863,000 34,669,000 104,941,000 74,822,000 69,671,000 118,057,000 113,954,000 73,060,000 125,478,000 71,643,000 78,138,000 25,170,000 45,455,000 47,779,000 44,472,000 17,008,000 21,098,000 21,116,000 35,186,000 61,724,000 147,661,000 156,778,000 114,766,000 36,085,000 141,985,000 126,652,000 69,808,000 54,634,000 30,584,000 79,136,000 2,931,000 -3,394,000 
      cash flows from investing activities:
    		                                   
      capital expenditures
    		-44,040,000 -37,131,000 -40,913,000 -27,848,000 -40,644,000 -37,220,000 -34,585,000 -50,122,000 -96,972,000 -108,936,000 -114,839,000 -72,519,000 -102,645,000 -80,196,000 -64,323,000 -55,823,000 -35,513,000 -29,693,000 -22,494,000 -14,094,000 -5,807,000 -33,412,000 -47,290,000 -108,551,000 -68,462,000 -146,969,000 -178,912,000 -72,045,000 -59,961,000 -77,043,000 -75,148,000 -92,071,000 -81,190,000 -61,720,000 -50,910,000 
      free cash flows
    		-2,380,000 17,083,000 13,776,000 10,015,000 -5,975,000 67,721,000 40,237,000 19,549,000 21,085,000 5,018,000 -41,779,000 52,959,000 -31,002,000 -2,058,000 -39,153,000 -10,368,000 12,266,000 14,779,000 -5,486,000 7,004,000 15,309,000 1,774,000 14,434,000 39,110,000 88,316,000 -32,203,000 -142,827,000 69,940,000 66,691,000 -7,235,000 -20,514,000 -61,487,000 -2,054,000 -58,789,000 -54,304,000 
      business acquisition, net of cash acquired
    		    0                               
      proceeds from sale of assets
    		998,000 912,000 7,764,000 3,352,000 964,000 1,182,000 738,000 981,000 5,932,000 955,000 1,089,000 1,370,000 4,256,000 2,676,000 275,000 37,080,000 884,000 1,043,000 224,000 2,056,000 1,653,000 1,944,000 733,000 821,000 5,227,000 520,000 1,027,000 313,000 998,000 1,965,000 317,000 185,000 3,008,000 777,000 452,000 
      proceeds from note receivable from sale of business
    		541,000 531,000 313,000                                 
      net cash from investing activities
    		-42,501,000 -35,688,000 -32,836,000 -24,496,000 -39,680,000 -57,076,000 -33,847,000 -71,356,000 -91,040,000 -107,981,000 -113,750,000 -109,788,000 -98,389,000 -77,520,000 -64,048,000 -18,743,000 -34,629,000 -28,650,000 -22,270,000 -12,038,000 -4,154,000 -31,468,000 -46,557,000 -107,730,000 -63,235,000 -146,449,000 -177,885,000 -71,732,000 -58,963,000 -75,078,000 -74,831,000 -91,886,000 -78,182,000 -60,943,000 -50,458,000 
      cash flows from financing activities:
    		                                   
      payments of finance lease obligations
    		-4,598,000 -4,526,000 -4,705,000                                 
      repayments of equipment financing term loans
    		                                   
      repayments of insurance financing
    		-1,531,000 -1,503,000 -1,476,000             0 -1,380,000 -2,056,000 -2,037,000     0 -657,000 -1,956,000 -1,934,000 -1,277,000 0 -1,847,000 -1,371,000 -907,000 -424,000 -1,240,000 -1,236,000 
      payment of debt issuance costs
    		-329,000       0 0   0 0               -1,372,000 0 0 -360,000 0 0 -38,000 -1,615,000 
      tax withholdings paid for net settlement of equity awards
    		-24,000 -93,000 -2,723,000 -532,000 -107,000 -61,000 -1,209,000 -37,000 -123,000 -4,000 -3,379,000 -36,000 -57,000 -1,095,000 -2,691,000 -47,000 0 -159,000 -5,614,000 -16,000 -13,000 -129,000 -456,000             
      share repurchases
    		   -3,379,000 -10,233,000 -22,988,000 -22,508,000 -15,480,000 -18,788,000                           
      payment of excise tax on share repurchases
    		0                                   
      net cash from financing activities
    		-7,458,000 -7,078,000 -8,904,000 -9,490,000 -15,309,000 -27,437,000 -27,871,000 -19,291,000 -34,800,000 11,347,000 -3,379,000 29,964,000 165,000 -1,597,000 -2,272,000 605,000 -1,250,000 1,020,000 -7,651,000 5,457,000 -13,000 -110,129,000 -20,486,000 -86,000 -20,631,000 -11,556,000 88,618,000 -15,717,000 -16,628,000 -14,040,000 42,661,000 34,243,000 24,946,000 -2,505,000 5,881,000 
      net increase in cash and cash equivalents
    		-8,299,000 11,448,000 12,949,000          -26,581,000 -979,000 -41,150,000 27,317,000 11,900,000       39,845,000 72,912,000 -43,239,000 -53,182,000 54,536,000 51,061,000 -19,310,000 22,464,000     
      cash and cash equivalents - beginning of period
    		0 0 50,443,000          0 0 111,918,000  0 0 68,772,000  0 0 149,036,000  0 0 132,700,000  0 0 23,949,000  0 0 133,596,000 
      cash and cash equivalents - end of period
    		-8,299,000 11,448,000 63,392,000          -26,581,000 -979,000 70,768,000  11,900,000 16,842,000 55,859,000  16,949,000 -106,411,000 143,717,000  72,912,000 -43,239,000 79,518,000  51,061,000 -19,310,000 46,413,000  25,900,000 -60,517,000 85,625,000 
      unrealized gain on short-term investment
    		                                   
      supplemental disclosure of non-cash investing and financing activities:
    		                                   
      capital expenditures included in accounts payable and accrued liabilities
    		 16,701,000 12,435,000  -3,809,000 -5,271,000 26,859,000  -37,891,000                           
      equipment purchases financed and corresponding issuances of loans
    		                                   
      leasehold improvements financed by operating lease landlord
    		                                   
      business acquisition deferred cash consideration included in other current liabilities
    		    -537,000                               
      business acquisition contingent consideration included in other long-term liabilities
    		    0                               
      goodwill impairment expense
    		                                   
      deferred income tax (benefit) expense
    		   -4,112,000                                
      stock‑based compensation
    		                                   
      benefit from credit losses
    		               0 142,000   0 0 -3,843,000 4,291,000             
      loss on disposal of assets and businesses
    		                                   
      noncash income from settlement with equipment manufacturer
    		                                   
      business acquisitions, net of cash acquired
    		                                   
      proceeds from borrowings
    		       0 0               0 20,000,000 0 90,000,000 0 20,000,000 10,643,000 46,735,000 32,933,000 26,880,000   
      repayments of borrowings
    		       0            0 0 -110,000,000 -20,000,000 0 -40,000,000   -19,088,000 -36,628,000 -22,887,000 -2,343,000 -1,908,000 -1,510,000 -1,459,000 -161,669,000 
      payments of finance lease obligation
    		                                   
      proceeds from exercise of equity awards
    		           0 222,000 322,000 419,000 652,000 130,000       0 89,000 523,000 552,000 196,000 0       
      payment of excise taxes on share repurchases
    		                                   
      net increase in cash, cash equivalents and restricted cash
    		     20,428,000 13,104,000    -44,069,000                         
      cash, cash equivalents and restricted cash — beginning of year
    		                                   
      cash, cash equivalents and restricted cash — end of year
    		                                   
      impairment expense
    		           0 0       21,348,000 0 0 16,654,000             
      unrealized loss on short-term investment
    		      602,000 418,000 -1,726,000 52,000 3,794,000 -1,779,000                        
      noncash gain from adjustment of business acquisition contingent consideration
    		                                   
      changes in operating assets and liabilities, net of effects of business acquisition:
    		                                   
      payments on finance lease obligations
    		    -4,525,000 -4,388,000 -4,154,000                             
      cash, cash equivalents and restricted cash - beginning of period
    		     0 33,354,000  0 0 88,862,000                         
      cash, cash equivalents and restricted cash - end of period
    		     20,428,000 46,458,000  -7,783,000 17,320,000 44,793,000                         
      non-cash income from settlement with equipment manufacturer
    		                                   
      accrued interest
    		       25,000 -145,000 475,000 28,000         0 0 -263,000 -131,000 -175,000 -61,000 -61,000 480,000 -269,000 -26,000 588,000 468,000 -9,000 85,000 0 -108,000 
      non cash income from settlement with equipment manufacturer
    		                                   
      net decrease in cash, cash equivalents and restricted cash
    		        -7,783,000                           
      silvertip acquisition, net of cash acquired
    		                                   
      payment of finance lease obligation
    		                   0 0 0 -30,000 -86,000 -63,000           
      proceeds from insurance financing
    		                                   
      accrued liabilities
    		                              -3,252,000 2,341,000 3,194,000 -45,000 -2,560,000 
      cash and cash equivalents — beginning of year
    		                                   
      cash and cash equivalents — end of year
    		                                   
      deferred income tax benefit
    		                -1,279,000 -3,697,000 -6,663,000                 
      net decrease in cash and cash equivalents
    		                  -12,913,000  16,949,000 -106,411,000 -5,319,000          25,900,000 -60,517,000 -47,971,000 
      amortization of deferred revenue rebate
    		                           0 0 153,000 462,000 461,000 462,000 461,000 462,000 
      benefit from bad debt expense
    		                       474,000 0           
      gain loss on interest rate swap
    		                                   
      proceeds from initial public offering
    		                                   
      payment of initial public offering costs
    		                                   
      loss on disposal of fixed assets
    		                          19,228,000  15,094,000 20,275,000 7,529,000     
      gain on extinguishment of debt
    		                                   
      extinguishment of debt
    		                                   
      payment of debt extinguishment costs
    		                                   
      proceeds from additional common equity capitalization
    		                                   
      proceeds from preferred equity capitalization
    		                                   
      payment of preferred equity capitalization costs
    		                                   
      proceeds from ipo
    		                               0 0 0 185,500,000 
      payment of deferred ipo costs
    		                                   
      gain on interest rate swap
    		                                   
      payment of ipo costs
    		                                0 0 -15,099,000 
      (gain) loss on interest rate swap
    		                                 -61,000 -138,000 
      gain on extinguishment
    		                                   
      debt extinguishment cost
    		                                   
      equity capitalization
    		                                   
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.